260 related articles for article (PubMed ID: 1970928)
21. Gastric carcinoid tumors: the biology and therapy of an enigmatic and controversial lesion.
Gilligan CJ; Lawton GP; Tang LH; West AB; Modlin IM
Am J Gastroenterol; 1995 Mar; 90(3):338-52. PubMed ID: 7872269
[TBL] [Abstract][Full Text] [Related]
22. Progression of gastric enterochromaffin-like cells growth in Zollinger-Ellison syndrome and atrophic body gastritis patients.
Delle Fave G; Marignani M; Corleto VD; Angeletti S; D'Ambra G; Ferraro G; D'Adda T; Azzoni C; Jensen RT; Annibale B; Bordi C
Dig Liver Dis; 2002 Apr; 34(4):270-8. PubMed ID: 12038811
[TBL] [Abstract][Full Text] [Related]
23. Gastric carcinoids in patients with hypergastrinemia.
Jordan PH; Barroso A; Sweeney J
J Am Coll Surg; 2004 Oct; 199(4):552-5. PubMed ID: 15454137
[TBL] [Abstract][Full Text] [Related]
24. The Zollinger-Ellison syndrome due to an infiltrating tumour of the stomach.
Royston CM; Brew DS; Garnham JR; Stagg BH; Polak J
Gut; 1972 Aug; 13(8):638-42. PubMed ID: 4562021
[TBL] [Abstract][Full Text] [Related]
25. Gallbladder and gastric argyrophil carcinoid associated with a case of Zollinger-Ellison syndrome.
Barone GW; Schaefer RF; Counce JS; Eidt JF
Am J Gastroenterol; 1992 Mar; 87(3):392-4. PubMed ID: 1539581
[TBL] [Abstract][Full Text] [Related]
26. Mixed type Zollinger-Ellison syndrome in a florid case of multiple endocrine neoplasia type I. A case report.
Duggan M; Anderson C
Am J Clin Pathol; 1984 Oct; 82(4):481-6. PubMed ID: 6148008
[TBL] [Abstract][Full Text] [Related]
27. Gastric carcinoids and neuroendocrine carcinomas: pathogenesis, pathology, and behavior.
Rindi G; Bordi C; Rappel S; La Rosa S; Stolte M; Solcia E
World J Surg; 1996 Feb; 20(2):168-72. PubMed ID: 8661813
[TBL] [Abstract][Full Text] [Related]
28. Carcinogenic hypergastrinemia: signet-ring cell carcinoma in a patient with multiple endocrine neoplasia type 1 with Zollinger-Ellison's syndrome.
Schott M; Sagert C; Willenberg HS; Schinner S; Ramp U; Varro A; Raffel A; Eisenberger C; Zacharowski K; Perren A; Scherbaum WA
J Clin Endocrinol Metab; 2007 Sep; 92(9):3378-82. PubMed ID: 17609302
[TBL] [Abstract][Full Text] [Related]
29. Gastric endocrine cell evolution in patients with Zollinger-Ellison syndrome. Influence of gastrinoma growth and long-term omeprazole treatment.
Cadiot G; Lehy T; Ruszniewski P; Bonfils S; Mignon M
Dig Dis Sci; 1993 Jul; 38(7):1307-17. PubMed ID: 8100759
[TBL] [Abstract][Full Text] [Related]
30. Expression of vesicular monoamine transporters in endocrine hyperplasia and endocrine tumors of the oxyntic stomach.
Eissele R; Anlauf M; Schäfer MK; Eiden LE; Arnold R; Weihe E
Digestion; 1999; 60(5):428-39. PubMed ID: 10473967
[TBL] [Abstract][Full Text] [Related]
31. Partial gastric corpectomy results in hypergastrinemia and development of gastric enterochromaffinlike-cell carcinoids in the rat.
Mattsson H; Havu N; Bräutigam J; Carlsson K; Lundell L; Carlsson E
Gastroenterology; 1991 Feb; 100(2):311-9. PubMed ID: 1985029
[TBL] [Abstract][Full Text] [Related]
32. Histomorphological characteristics of gastric mucosa in patients with Zollinger-Ellison syndrome or autoimmune gastric atrophy: role of gastrin and atrophying gastritis.
Lehy T; Roucayrol AM; Mignon M
Microsc Res Tech; 2000 Mar; 48(6):327-38. PubMed ID: 10738314
[TBL] [Abstract][Full Text] [Related]
33. Carcinoid tumors of the stomach: a clinical and radiographic study.
Binstock AJ; Johnson CD; Stephens DH; Lloyd RV; Fletcher JG
AJR Am J Roentgenol; 2001 Apr; 176(4):947-51. PubMed ID: 11264084
[TBL] [Abstract][Full Text] [Related]
34. Morphometry of gastric endocrine cells in hypergastrinemic patients treated with the somatostatin analogue octreotide.
Bordi C; Azzoni C; Pilato FP; Robutti F; D'Ambra G; Caruana P; Rindi G; Corleto VD; Annibale B; Delle Fave G
Regul Pept; 1993 Sep; 47(3):307-18. PubMed ID: 8234912
[TBL] [Abstract][Full Text] [Related]
35. Endocrine tumours of the stomach.
Delle Fave G; Capurso G; Milione M; Panzuto F
Best Pract Res Clin Gastroenterol; 2005 Oct; 19(5):659-73. PubMed ID: 16253892
[TBL] [Abstract][Full Text] [Related]
36. Gastric endocrine cells in omeprazole-treated and untreated patients with the Zollinger-Ellison syndrome.
Bardram L; Thomsen P; Stadil F
Digestion; 1986; 35 Suppl 1():116-22. PubMed ID: 3792668
[TBL] [Abstract][Full Text] [Related]
37. [Anomalies of fundic argyrophil cell proliferation (enterochromaffin-like cells) in Zollinger-Ellison syndrome].
Cadiot G; Lehy T; Ruszniewski P; Sobhani I; Vallot T; Mignon M
Gastroenterol Clin Biol; 1991; 15(5 ( Pt 2)):41C-46C. PubMed ID: 1916118
[No Abstract] [Full Text] [Related]
38. Hyperplastic, dysplastic, and neoplastic enterochromaffin-like-cell proliferations of the gastric mucosa. Classification and histogenesis.
Solcia E; Fiocca R; Villani L; Luinetti O; Capella C
Am J Surg Pathol; 1995; 19 Suppl 1():S1-7. PubMed ID: 7762735
[TBL] [Abstract][Full Text] [Related]
39. Optimal treatment of Zollinger-Ellison syndrome and related conditions in elderly patients.
Tomassetti P; Salomone T; Migliori M; Campana D; Corinaldesi R
Drugs Aging; 2003; 20(14):1019-34. PubMed ID: 14651442
[TBL] [Abstract][Full Text] [Related]
40. [A case of gastric carcinoid tumor with multiple liver metastasis].
Lee HL; Jeon YC; Kim JB; Park JY; Han DS; Hyun SJ; Choi HS; Hahm JS; Jang SJ; Park YW
Korean J Gastroenterol; 2003 Jul; 42(1):81-5. PubMed ID: 14532737
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
